Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in CLL Workshop February 27, 2013 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food a - Rothmann - Document - PDFSEARCH.IO

First Page	Meta Content
	Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in CLL Workshop February 27, 2013 The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food a Add to Reading List Open Document File Size: 44,44 KB Share Result on Facebook Facility Robert Temple / / MedicalCondition HIV / disease / Endpoints Mark Rothmann Minimal Residue Disease / / Organization U.S. Food and Drug Administration / National Institute of Health / / Person Mark Rothmann / Thomas Fleming / / SocialTag Clinical trials Research Medical statistics Medical research Medical terms Surrogate endpoint Clinical endpoint Biomarker Randomized controlled trial Medicine

Surrogate Endpoints Mark Rothmann* Minimal Residue Disease in CLL Workshop February 27, 2013 *The views expressed in this presentation are those of the presenters and do not necessarily represent those of the U.S. Food aAdd to Reading List